Eslicarbazepine acetate
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
31722-428 -
Package NDC
31722-428-30 -
Package NDC
31722-428-32 -
Application number
ANDA211186 -
SPL ID
35c91221-dff8-9144-e063-6394a90a57fb -
SPL set ID
6200ae2e-ac4e-41b6-a1c3-0ea00703d7e3 -
UNII
BEA68ZVB2K -
RxCUI
1482507 -
RxCUI
1482515 -
RxCUI
1482521 -
RxCUI
1482525
What the source publishes
- Labeler
- Camber Pharmaceuticals, Inc.
- Active ingredients
- Eslicarbazepine acetate
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Eslicarbazepine acetate",
"splId": "35c91221-dff8-9144-e063-6394a90a57fb",
"labels": [
{
"setId": "6200ae2e-ac4e-41b6-a1c3-0ea00703d7e3",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6200ae2e-ac4e-41b6-a1c3-0ea00703d7e3",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6200ae2e-ac4e-41b6-a1c3-0ea00703d7e3"
}
],
"routes": [
"ORAL"
],
"labeler": "Camber Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE (31722-428-30)",
"package_ndc": "31722-428-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20230803"
},
{
"sample": false,
"description": "10 BLISTER PACK in 1 CARTON (31722-428-32) / 10 TABLET in 1 BLISTER PACK (31722-428-31)",
"package_ndc": "31722-428-32",
"identifierStatus": "well-formed",
"marketing_start_date": "20230803"
}
],
"productId": "31722-428_35c91221-dff8-9144-e063-6394a90a57fb",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "31722-428",
"deaSchedule": null,
"genericName": "Eslicarbazepine acetate",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ESLICARBAZEPINE ACETATE",
"strength": "200 mg/1"
}
],
"applicationNumber": "ANDA211186",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20230803",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0331722431309",
"0331722430906",
"0331722428309",
"0331722430609",
"0331722429306",
"0331722431903"
],
"unii": [
"BEA68ZVB2K"
],
"rxcui": [
"1482507",
"1482515",
"1482521",
"1482525"
],
"spl_set_id": [
"6200ae2e-ac4e-41b6-a1c3-0ea00703d7e3"
],
"manufacturer_name": [
"Camber Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:31722-428_35c91221-dff8-9144-e063-6394a90a57fb"